Aerovate Therapeutics Inc...

NASDAQ: AVTE · Real-Time Price · USD
2.68
0.00 (0.00%)
At close: Apr 28, 2025, 3:59 PM

Aerovate Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-38.07 -276.15 -487.2 -438.65
PEG Ratio
2.54 -7.53 -39.61 4.60
PS Ratio
n/a n/a n/a n/a
PB Ratio
34.68 190.54 198.01 58.42
P/FCF Ratio
-37.23 -366.4 -638.3 -365.22
P/OCF Ratio
-37.23 -367.32 -641.48 -367.63
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.01 0.01 0.01 0.00
Quick Ratio
20.93 7.04 16.90 68.37
Current Ratio
20.93 7.04 16.90 68.37
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a -354.18
Return on Equity
-0.91 -0.69 -0.41 -0.13
Return on Assets
-0.87 -0.59 -0.38 -0.13
Return on Invested Capital
-0.97 -0.74 -0.42 -0.13
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a